Company · CIK 1804585

# NUGENEREX IMMUNO-ONCOLOGY, INC.

| CIK | [1804585](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001804585) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | TX |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2020-06-17 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-248789 | Registered company Dormant | 2020-09-14 | 2021-05-20 | 3 |
| 333-248792 | Registered company Dormant | 2020-09-14 | 2020-09-14 | 1 |
| 333-248796 | Registered company Dormant | 2020-09-14 | 2020-09-14 | 1 |

## Filings

 5

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2021-05-20 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1804585/000160706221000134/0001607062-21-000134-index.htm) Amendment | 333-248789 | 0001607062-21-000134 |
| 2021-05-19 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1804585/000160706221000131/0001607062-21-000131-index.htm) Amendment | 333-248789 | 0001607062-21-000131 |
| 2020-09-14 | [S-1](https://www.sec.gov/Archives/edgar/data/1804585/000160706220000276/0001607062-20-000276-index.htm) Registration filed | 333-248796 | 0001607062-20-000276 |
| 2020-09-14 | [S-1](https://www.sec.gov/Archives/edgar/data/1804585/000160706220000274/0001607062-20-000274-index.htm) Registration filed | 333-248792 | 0001607062-20-000274 |
| 2020-09-14 | [S-1](https://www.sec.gov/Archives/edgar/data/1804585/000160706220000272/0001607062-20-000272-index.htm) Registration filed | 333-248789 | 0001607062-20-000272 |

[All filings of this company](https://equitycapital.markets/filings?cik=1804585) · [CSV](https://equitycapital.markets/filings.csv?cik=1804585)

---
Source page: https://equitycapital.markets/company/1804585 · Data: U.S. SEC EDGAR · CC BY 4.0